Synthetic Biology: DNA Cloning Market by Type of Cloning Method (Blunt End Cloning, Ligase Independent Cloning, PCR Cloning, Seamless Cloning, TA Cloning and Other Methods), End-Users (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Other End-Users) and Key Geographical Regions (North America, Europe, Asia Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    May 2022

  • Pages
    238

  • View Count
    1511

Example Insights

Synthetic-Biology-DNA-Cloning-Market-Context-thumb Synthetic-Biology-DNA-Cloning-Market-List-of-DNA-Cloning-Kits-thumb Synthetic-Biology-DNA-Cloning-Market-Distribution-by-Number-of-Reactions-thumb Synthetic-Biology-DNA-Cloning-Market-List-of-DNA-Cloning-Reagents-thumb
Synthetic-Biology-DNA-Cloning-Market-Distribution-by-Unit-Size-thumb Synthetic-Biology-DNA-Cloning-Market-Geographical-Distribution-thumb Synthetic-Biology-DNA-Cloning-Market-Publication-Analysis-thumb Synthetic-Biology-DNA-Cloning-Market-Academic-Grant-Analysis-thumb
Synthetic-Biology-DNA-Cloning-Market-Patent-Analysis-thumb Synthetic-Biology-DNA-Cloning-Market-Growth-Scenarios-thumb    

Overview

The field of gene cloning remained a largely unexplored area until 1973, when A. C. Y. Chang, H. W. Boyer, R. B. Helling and Stanley N. Cohen reported that individual genes can be cloned and isolated by cleaving DNA enzymatically into DNA fragments. Over time, the evolution of genome engineering techniques has allowed for alterations in the genome of microorganisms, thereby enabling the production of substances having various research and therapeutic applications. DNA cloning, which is a highly regulated method, is widely acknowledged and employed in many laboratories throughout the world. Specifically, during the COVID-19 pandemic, several well-known pharmaceutical and biopharmaceutical companies, as well as synthetic biology market players, have stepped forward and contributed to the research and development of a variety of products, such as test kits, treatment solutions, and vaccines to combat the coronavirus infection using synthetic biology. Based on the requirement, a variety of approaches, such as traditional cloning, PCR cloning, ligation independent cloning, seamless cloning and recombinational cloning, can be used to clone the DNA. Despite several advancements in the field of synthetic biology, the DNA cloning process is associated with various challenges, such as requirement of large amounts of expensive vectors for cloning, different reagents and longer time duration for the completion of process. 

In order to overcome these drawbacks, innovators in the pharmaceutical industry have undertaken several efforts for identifying and developing ways to improve the process of DNA cloning. Among other alternatives, the use of DNA cloning kits has emerged as a viable option for various drug developers and academic / research institutes to overcome the challenges associated with the traditional DNA cloning methods. Presently, more than 250 DNA cloning kits are available in the market. These cloning kits are affordable, easy to use and produce high quality results in short duration. Further, more than 3,200 patents and 4,000 research articles have been published for DNA cloning technologies in the past few years; this is indicative of the innovative efforts of the stakeholders engaged in this domain. Driven by the increasing demand for gene therapies and the introduction of novel and advanced DNA cloning technologies, the DNA cloning market is anticipated to witness steady growth in the coming years.

Scope of the Report

The “Synthetic Biology: DNA Cloning Market, 2022-2035: Distribution by Type of Cloning Method (Blunt End Cloning, Ligase Independent Cloning, PCR Cloning, Seamless Cloning, TA Cloning and Other Methods), End-Users (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Other End-Users) and Key Geographical Regions (North America, Europe, Asia Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study of the current market landscape and future potential of DNA cloning kits and reagents over the next decade. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. In addition to other elements, the report includes:

  • A detailed assessment of the current market landscape of DNA cloning kits, featuring information on the kit components (enzyme mix, vector, buffer, ligase and primer), number of reactions (between 1-35, between 36-50 and more than 50), type of cloning method used (ligation independent cloning, TA cloning, blunt cloning and in-fusion seamless cloning), type of fragment(s) cloned (multiple fragments, long fragments and short oligonucleotides), cloning time (5 minutes, between 10-30 minutes, between 31-60 minutes and more than 60 minutes) and kit shelf life (between 1-10 months, between 11-20 months, more than 20 months) and kit price (1-500 USD, 501-1500 USD, 1501-2500 USD, more than 2500 USD).  In addition to this, the chapter features information on DNA cloning kit providers and a detailed analysis based on several relevant parameters, such as year of establishment, company size, region of headquarters, location of headquarters, company size and region of headquarters and leading players (in terms of number of products).
  • A detailed assessment of the current market landscape of DNA cloning reagents, featuring information on reagent unit size (less than 500, 500-2,000 and more than 2,000), reagent concentration (less than 5 units/μl, 5-50 units/μl and more than 50 units/μl) reagent components (polymerase, buffers and additional components), exonuclease activity (5′–>3′ exonuclease activity and 3’-> 5’ exonuclease activity), product overhangs (3'A, blunt, 3', 5', 3'/blunt, 3'A/ blunt, 3'-dA and 5'/3'), storage temperature (-20°C,-30°C to -10 °C,-5 °C to -30 °C and -25 °C  to -15 °C)  and reagent price (less than USD 100, USD 100-500 and more than USD 500). In addition, the chapter features analysis related to DNA cloning reagents providers based on parameters, such as year of establishment, company size, region of headquarters, location of headquarters, company size and region of headquarters and leading players (in terms of number of products).
  • Elaborate profiles of prominent players offering DNA cloning kits and reagents (shortlisted based on number of products), based in North America, Europe and Asia Pacific. Each profile features a brief overview of the company, details related to its financials (if available), DNA cloning kit portfolio, DNA cloning reagent portfolio, recent developments and an informed future outlook.
  • An analysis of over 4,400 peer-reviewed scientific articles related to DNA cloning, published since 2018, based on several parameters, such as year of publication, type of article, type of publication, emerging focus areas, most popular publishers, most popular authors, and most popular journals.
  • An analysis of more than 1,200 grants related to DNA cloning, since 2017, based on several parameters, such as year of grant, amount of grant, administrating institute center, support period, type of grant application, purpose of grant, activity code, study section awarded, emerging focus areas, most popular program officers, popular recipient organizations, popular recipient organizations and geographical distribution of recipient organizations.
  • An in-depth analysis of over 3,400 patents that have been filed / granted for DNA cloning, between 2017-2021, based on multiple parameters, such as type of patent, publication year, application year, geography, CPC symbols, emerging focus areas, issuing authority involved, type of applicant, leading industry players, leading non-industry players, leading patent assignees, patent benchmarking analysis, patent characteristics and geography, patent age. It also includes a detailed patent valuation analysis and information on the leading patents.
  • A case study on the DNA cloning service providers, featuring information and detailed analysis based on their year of establishment, company size, location of headquarters, region of headquarters and company size and region of headquarters.
  • A case study on the general overview of advancements in DNA cloning, covering details related to the current and future trends in the domain. 

One of the key objectives of the report was to estimate the future growth potential of synthetic biology: DNA cloning (kits and reagents) market, over the coming decade. We have provided informed estimates on the financial evolution of the market for the period 2022-2035. For this purpose, we have segmented the future opportunity across types of cloning methods (blunt end cloning, ligase independent cloning, PCR cloning, seamless cloning, TA cloning and other methods), end-users (academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and other end-users) and key geographical regions (North America, Europe, Asia Pacific, Latin America, and Middle East and North Africa). In order to account for uncertainties and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the anticipated industry’s growth.

The opinions and insights presented in the report were influenced by survey inputs from various experienced stakeholders in the industry. The report features detailed insights of respondents who participated in the study (in alphabetical order)

  • Jesús C. Morales (Business Development Manager, Canvax Biotech)
  • Anonymous, SBS Genetech

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Who are the key players engaged in the development of DNA cloning kits and reagents?
  • What is the focus area of various publications related to DNA cloning?
  • Which research institutes have received relatively more grants for projects related to DNA cloning?
  • How has the intellectual property landscape of DNA cloning evolved over the last several years?
  • Which region(s) are likely to occupy the maximum market share in DNA cloning kits market?
  • Which factors are likely to influence the evolution of this market?
  • How is the current and future market opportunity related to DNA cloning kits likely to be distributed across key market segments?
  • Who are the key players offering services related to DNA cloning?

Contents

Chapter Outlines

Chapter 2 is an executive summary of the key insights captured during our research. It offers a high-level view on the likely evolution of the DNA cloning (kits and reagents) market in the mid to long term.

Chapter 3 provides a general overview of DNA cloning including information on the methods of DNA cloning. It also provides details on the types of DNA cloning kits and reagents (PCR cloning kits, TOPO cloning kits). In addition, the chapter discusses various advantages, applications, associated challenges and future perspectives of DNA cloning.

Chapter 4 provides an overview of the current market landscape of DNA cloning kits, based on several relevant parameters, such as information on the kit components (enzyme mix, vector, buffer, ligase and primer), number of reactions (between 1-35, between 36-50 and more than 50), type of cloning methods used (ligation independent, TA, blunt and in-fusion seamless cloning), type of fragment(s) cloned (multiple fragments, long fragments and short oligonucleotides), cloning time (5 minutes, between 10-30 minutes, between 31-60 minutes and more than 60 minutes) and kit shelf life (between 1-10 months, between 11-20 months, more than 20 months) and kit price (1-500 USD, 501-1500 USD, 1501-2500 USD and more than 2500 USD).  In addition, the chapter features information on DNA cloning kit providers and a detailed analysis based on several relevant parameters, such as year of establishment, company size, region of headquarters, location of headquarters, company size and region of headquarters and leading players (in terms of number of products).

Chapter 5 provides an overview of the current market landscape of DNA cloning reagents, based on several relevant parameters, such as reagent unit size (less than 500, 500-2,000 and more than 2,000), reagent concentration (less than 5 units/μ, 5-50 units/ and more than 50 units/μ) reagent  components (polymerase, buffers and additional components), exonuclease activity (5′–>3′ exonuclease activity and 3’-> 5’ exonuclease activity), product overhangs (3'A, blunt, 3', 5', 3'/blunt, 3'A/ blunt, 3'-dA and 5'/3'), storage temperature (-20°C,-30°C to -10 °C,-5 °C to -30 °C and -25 °C  to -15 °C)  and reagent price (less than USD 100, USD 100-500 and more than USD 500). In addition, the chapter features analysis related to DNA cloning reagents providers based on parameters, such as year of establishment, company size, region of headquarters, location of headquarters, company size and region of headquarters and leading players (in terms of number of products).

Chapter 6 includes elaborate profiles of prominent players offering DNA cloning kits and reagents (shortlisted based on number of products), based in North America, Europe and Asia Pacific. Each profile features a brief overview of the company, details related to its financials (if available), DNA cloning kit portfolio, DNA cloning reagent portfolio, recent developments and an informed future outlook.

Chapter 7 features a detailed review of over 4,400 peer-reviewed scientific articles related to DNA cloning, published since 2018, based on several parameters, such as year of publication, type of article, type of publication, emerging focus areas, most popular publishers, most popular authors publishers, and most popular journals.

Chapter 8 provides an in-depth analysis of grants that have been awarded to various research institutes for projects related to DNA cloning, during 2017-2022, on the basis of important parameters, such as year of grant, amount of grant, administrating institute center, support period, type of grant application, purpose of grant, activity code, study section awarded, emerging focus areas, most popular program officers, popular recipient organizations, popular recipient organizations. This chapter also includes geographical distribution of recipient organizations.

Chapter 9 features an in-depth analysis of the patents that have been filed / granted for DNA cloning, between 2017-2021, on the basis of various relevant parameters, such as type of patent, publication year, application year, geography,  CPC symbols, emerging focus areas, issuing authority involved,  type of applicant, leading industry players, leading non- industry players,  leading patent assignees, patent benchmarking analysis, patent characteristics and geography, patent age In addition, it includes a detailed patent valuation analysis and leading patents.

Chapter 10 presents an insightful market forecast analysis, highlighting the future potential of the DNA cloning kits market till the year 2035. In order to provide a detailed future outlook, our projections have been segmented across types of cloning methods (blunt end cloning, ligase independent cloning, PCR cloning, seamless cloning, TA cloning and other methods), End-User (academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics and other end-users), key geographical regions (North America, Europe and Asia-Pacific, Latin America and, Middle East and North Africa)

Chapter 11 presents a case study of the DNA cloning service providers. The chapter features information and detailed analysis on their year of establishment, company size, location of headquarters, region of headquarters and company size and region of headquarters.

Chapter 12 is a case study on the evolution of DNA cloning, providing an includes overview on the advancements in DNA cloning with the innovation of Xenobots- Novel Living Machines. It also discusses various applications of xenobots along with its ethical issues and future perspectives.

Chapter 13 is a summary of the overall report, presenting the insights on the market trends and the likely evolution of the DNA cloning kits and reagents market.

Chapter 14 is a collection of survey inputs from various experienced stakeholders in the industry. In this chapter, we have presented detailed insights of respondents who participated in the study. 

Chapter 15 is an appendix that contains tabulated data and numbers for all the figures in the report.

Chapter 16 is an appendix that provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to DNA Cloning
3.3. Methods of DNA Cloning
3.3.1. Restriction Enzyme Based Cloning
3.3.2. PCR Cloning
3.3.3. Ligation Independent Cloning
3.3.4. TA Cloning
3.3.5. Seamless Cloning
3.3.6. Recombinational Cloning

3.4. DNA Cloning Kits
3.4.1. PCR Cloning Kits
3.4.2. TOPO Cloning Kits

3.5. DNA Cloning Reagents
3.5.1. Taq Polymerase
3.5.2. Hot-Start DNA Polymerase
3.5.3. Processivity-Enhancing Domain

3.6. DNA Cloning Tools
3.6.1. Advantages of Cloning tools

3.7. Challenges associated with DNA Cloning
3.8. Applications of DNA Cloning
3.8.1. Medicinal Applications
3.8.2. Agricultural Applications
3.8.3. Gene Therapy
3.8.4. Genomic Library

3.9. Future Perspectives

4. MARKET LANDSCAPE: DNA CLONING KITS
4.1. Chapter Overview
4.2. DNA Cloning Kits: Overall Market Landscape
4.2.1 Analysis by Kit Components
4.2.2. Analysis by Number of Reactions
4.2.3. Analysis by Type of Cloning Method Used
4.2.4 Analysis by Type of Fragment(s) Cloned
4.2.5. Analysis by Cloning Time
4.2.6. Analysis by Efficacy
4.2.7. Analysis by Kit Shelf Life
4.2.8. Analysis by Kit Price

4.3. DNA Cloning Kits: Developer Landscape 
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size 
4.3.3. Analysis by Region of Headquarters
4.3.4. Analysis by Location of Headquarters
4.3.5. Analysis by Company Size and Region of Headquarters
4.3.6. Leading Players: Analysis by Number of DNA Cloning Kits

5. MARKET LANDSCAPE: DNA CLONING REAGENTS
5.1. Chapter Overview
5.2. DNA Cloning Reagents: Overall Market Landscape
5.2.1. Analysis by Unit Size
5.2.2. Analysis by Reagent Concentration
5.2.3. Analysis by Reagent Components
5.2.4. Analysis by Exonuclease Activity
5.2.5. Analysis by Product Overhangs
5.2.6. Analysis by Heat Inactivation Temperature 
5.2.7. Analysis by Storage Temperature 
5.2.8. Analysis by Reagent Price

5.3. DNA Cloning Reagents: Developer Landscape 
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Region of Headquarters
5.3.4. Analysis by Location of Headquarters
5.3.5. Analysis by Company Size and Region of Headquarters
5.3.6. Leading Players: Analysis by Number of DNA Cloning Reagents

6. DNA CLONING KITS AND REAGENTS: COMPANY PROFILES
6.1. Chapter Overview
6.2. Thermo Fisher Scientific
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. DNA Cloning Kit Portfolio
6.2.4. DNA Cloning Reagent Portfolio
6.2.5. Recent Developments and Future Outlook

6.3. Merck
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. DNA Cloning Kit Portfolio
6.3.4. DNA Cloning Reagent Portfolio
6.3.5. Recent Developments and Future Outlook

6.4. Takara Bio
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. DNA Cloning Kit Portfolio
6.4.4. DNA Cloning Reagent Portfolio
6.4.5. Recent Developments and Future Outlook

6.5. Vazyme
6.5.1. Company Overview
6.5.2. DNA Cloning Kit Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. GenScript
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. DNA Cloning Kit Portfolio
6.6.4. Recent Developments and Future Outlook

6.7. Promega
6.7.1. Company Overview
6.7.2. DNA Cloning Reagent Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Agilent Technologies
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. DNA Cloning Reagent Portfolio
6.8.4. Recent Developments and Future Outlook

6.9. Bio-Rad
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. DNA Cloning Reagent Portfolio
6.9.4. Recent Developments and Future Outlook

7. PUBLICATION ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.2.1. Analysis by Year of Publication
7.2.2. Analysis by Type of Article
7.2.3. Analysis by Type of Publication
7.2.4. Word Cloud: Emerging Focus Areas
7.2.5. Popular Publishers: Analysis by Number of Publications
7.2.6. Popular Journals: Analysis by Number of Publications
7.2.7. Popular Journals: Analysis of Journal Impact Factor
7.2.8. Analysis by Geography

8. GRANT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.2.1. Analysis by Year of Grant Award
8.2.2. Analysis by Amount Awarded
8.2.3. Analysis by Administering Institute Center
8.2.4. Analysis by Support Period
8.2.5. Analysis by Administering Institute Center and Support Period
8.2.6. Analysis by Type of Grant Application
8.2.7. Analysis by Purpose of Grant
8.2.8. Analysis by Purpose of Grant and Amount Awarded
8.2.9. Analysis by Activity Code
8.2.10. Analysis by Study Section Involved
8.2.11. Word Cloud: Emerging Focus Areas
8.2.12. Prominent Program Officers: Analysis by Number of Grants
8.2.13. Popular Recipient Organizations: Analysis by Number of Grants
8.2.14. Popular Recipient Organizations: Analysis by Amount Awarded
8.2.15. Grant Analysis: Geographical Distribution of Recipient Organizations

9. PATENT ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.2.1. Analysis by Type of Patent
9.2.2. Analysis by Publication Year
9.2.3. Analysis by Application Year
9.2.4. Analysis by Geography
9.2.5. Analysis by CPC Symbols
9.2.6. Word Cloud: Emerging Focus Areas
9.2.7. Analysis by Type of Organization
9.2.8. Leading Industry Players: Analysis by Number of Patents
9.2.9. Leading Non-Industry Players: Analysis by Number of Patents
9.2.10. Leading Patent Assignees: Analysis by Number of Patents
9.2.11. DNA Cloning: Patent Benchmarking Analysis
9.2.12. Analysis by Patent Characteristics
9.2.13. Analysis by Patent Age
9.2.14. DNA Cloning: Patent Valuation Analysis
9.2.15 Leading Patents by Number of Citations

10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global DNA Cloning Kits Market, 2022-2035
10.3.1. DNA Cloning Kits Market, 2022- 2035: Distribution by Type of Cloning Method
10.3.1.1. DNA Cloning Kits Market for Blunt End Cloning, 2022-2035
10.3.1.2. DNA Cloning Kits Market for Ligase Independent Cloning, 2022-2035
10.3.1.3. DNA Cloning Kits Market for PCR Cloning, 2022-2035
10.3.1.4. DNA Cloning Kits Market for Seamless Cloning, 2022-2035
10.3.1.5. DNA Cloning Kits Market for TA Cloning, 2022-2035
10.3.1.6. DNA Cloning Kits Market for Other Methods, 2022-2035

10.3.2 DNA Cloning Kits Market, 2022 and 2035: Distribution by End User
10.3.2.1. DNA Cloning Kits Market for Academic and Research Institutes, 2022-2035
10.3.2.2. DNA Cloning Kits Market for Pharmaceutical and Biotechnology Companies, 2022-2035
10.3.2.3. DNA Cloning Kits Market for Hospitals and Clinics, 2022-2035
10.3.2.4. DNA Cloning Kits Market for Other End-users, 2022-2035

10.3.3. DNA Cloning Kits Market: Distribution by Key Geographical Regions, 2022-2035
10.3.3.1. DNA Cloning Kits Market in North America, 2022-2035
10.3.3.2. DNA Cloning Kits Market in Europe, 2022-2035
10.3.3.3. DNA Cloning Kits Market in Asia-Pacific, 2022-2035
10.3.3.4. DNA Cloning Kits Market in Latin America, 2022-2035
10.3.3.5. DNA Cloning Kits Market in Middle East and North Africa, 2022-2035

11. CASE STUDY: DNA CLONING SERVICE PROVIDERS
11.1. Chapter Overview
11.2 DNA Cloning Service Providers: List of Players
11.2.1. Analysis by Year of Establishment
11.2.2. Analysis by Company Size
11.2.3. Analysis by Region of Headquarters
11.2.4. Analysis by Location of Headquarters
11.2.5. Analysis by Company Size and Region of Headquarters

12. EVOLUTION OF DNA CLONING
12.1. Chapter Overview
12.2. Introduction of AI in Synthetic Biology
12.2.1. Xenobots- Novel Living Machines
12.2.2. Applications of Xenobots
12.2.3. Ethical Issues
12.2.4. Future of Xenobots
12.3. Conclusion

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS
14.1. Chapter Overview

14.2. SBS Genetech
14.2.1. Company Snapshot
14.2.2. Interview Transcript

14.3. Canvax Biotech
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Jesús C. Morales, Business Development Manager

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Market Forecast
Figure 2.2 Executive Summary: DNA Cloning Kits Market Landscape
Figure 2.3 Executive Summary: DNA Cloning Reagents Market Landscape
Figure 2.4 Executive Summary: Publications Analysis
Figure 2.5 Executive Summary: Grant Analysis
Figure 2.6 Executive Summary: Patent Analysis
Figure 3.1 Mechanism of Restriction Enzyme Based Cloning
Figure 3.2 Mechanism of PCR Cloning
Figure 3.3 Mechanism of Ligation-Independent Cloning
Figure 3.4 Mechanism of TA Cloning
Figure 3.5 Mechanism of Seamless Cloning
Figure 3.6 Mechanism of Recombinational Cloning
Figure 3.7 Applications of DNA Cloning
Figure 4.1 DNA Cloning Kits: Distribution by Kit Components
Figure 4.2 DNA Cloning Kits: Distribution by Number of Reactions
Figure 4.3 DNA Cloning Kits: Distribution by Type of Cloning Method Used
Figure 4.4 DNA Cloning Kits: Distribution by Type of Fragment(s) Cloned
Figure 4.5 DNA Cloning Kits: Distribution by Cloning Time
Figure 4.6 DNA Cloning Kits: Distribution by Efficacy
Figure 4.7 DNA Cloning Kits: Distribution by Kit Shelf Life
Figure 4.8. DNA Cloning Kits: Distribution by Kit Price
Figure 4.9 DNA Cloning Kit Providers: Distribution by Year of Establishment
Figure 4.10 DNA Cloning Kit Providers: Distribution by Company Size
Figure 4.11 DNA Cloning Kit Providers: Distribution by Region of Headquarters
Figure 4.12 DNA Cloning Kit Providers: Distribution by Location of Headquarters
Figure 4.13 DNA Cloning Kit Providers: Distribution by Company Size and Region of Headquarters
Figure 4.14 Leading Players: Distribution by Number of DNA Cloning Kits
Figure 5.1 DNA Cloning Reagents: Distribution by Unit Size
Figure 5.2 DNA Cloning Reagents: Distribution by Reagent Concentration (units/μl)
Figure 5.3 DNA Cloning Reagents: Distribution by Reagent Components
Figure 5.4 DNA Cloning Reagents: Distribution by Exonuclease Activity
Figure 5.5 DNA Cloning Reagents: Distribution by Product Overhangs
Figure 5.6 DNA Cloning Reagents: Distribution by Heat Inactivation Temperature
Figure 5.7 DNA Cloning Reagents: Distribution by Storage Temperature
Figure 5.8 DNA Cloning Reagents: Distribution by Reagent Price
Figure 5.9 DNA Cloning Reagent Providers: Distribution by Year of Establishment
Figure 5.10 DNA Cloning Reagent Providers: Distribution by Company Size
Figure 5.11 DNA Cloning Reagent Providers: Distribution by Region of Headquarters
Figure 5.12 DNA Cloning Reagent Providers: Distribution by Location of Headquarters
Figure 5.13 DNA Cloning Reagent Providers: Distribution by Company Size and Region of Headquarters
Figure 5.14 Leading Players: Distribution by Number of Reagents
Figure 6.1 Thermo Fisher Scientific: Annual Revenues, 2017-2021 (USD Billion)
Figure 6.2 Merck: Annual Revenues, 2017- 2021 (EUR Billion)
Figure 6.3 Takara Bio: Annual Revenues, 2017-9M 2022 (JPY Billion)
Figure 6.4 GenScript: Annual Revenues, 2016- 2021 (USD Billion)
Figure 6.5 Agilent Technologies: Annual Revenues, 2017- 1M 2022 (USD Billion)
Figure 6.6 Bio-Rad: Annual Revenues, 2017- 2021 (USD Billion)
Figure 7.1 Publication Analysis: Cumulative Year-wise Trend, 2018-2022 (till January)
Figure 7.2 Publication Analysis: Distribution by Type of Article
Figure 7.3 Publication Analysis: Distribution by Type of Publication
Figure 7.4 Word Cloud: Key focus Areas
Figure 7.5 Popular Publishers: Distribution by Number of Publications
Figure 7.6 Popular Journals: Distribution by Number of Publications
Figure 7.7 Popular Journals: Distribution by Journal Impact Factor
Figure 7.8 Publication Analysis: Distribution by Geography
Figure 8.1 Grant Analysis: Cumulative Year-Wise Trend, 2017-2022 (till January)
Figure 8.2 Grant Analysis: Distribution by Amount Awarded (USD Million), 2017-2022 (till January)
Figure 8.3 Grant Analysis: Distribution by Administering Institute Center
Figure 8.4 Grant Analysis: Distribution by Support Period
Figure 8.5 Grant Analysis: Distribution by Administering Institute Center and Support Period
Figure 8.6 Grant Analysis: Distribution by Type of Grant Application
Figure 8.7 Grant Analysis: Distribution by Purpose of Grant Award
Figure 8.8 Grant Analysis: Distribution of Amount Awarded by Purpose of Grant
Figure 8.9 Grant Analysis: Distribution by Activity Code
Figure 8.10 Grant Analysis: Distribution by Study Section
Figure 8.11 Word Cloud: Emerging Focus Areas
Figure 8.12 Popular program officers: Distribution by Number of Grants
Figure 8.13 Popular Recipient Organizations: Distribution by Number of Grants
Figure 8.14 Popular Recipient Organization: Distribution by Amount Awarded (USD Million)
Figure 8.15 Grant Analysis: Distribution by Location of Recipient Organizations
Figure 9.1 Patent Analysis: Distribution by Type of Patent
Figure 9.2 Patent Analysis: Cumulative Distribution by Publication Year, 2017-2021
Figure 9.3 Patent Analysis: Cumulative Distribution by Application Year, 2017-2022
Figure 9.4 Patent Analysis: Distribution by Geographical Location
Figure 9.5 Patent Analysis: Distribution by CPC Symbols
Figure 9.6 Word Cloud: Emerging Focus Areas
Figure 9.7 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2017-2021
Figure 9.8 Leading Industry Players: Distribution by Number of Patents
Figure 9.9 Leading Non-Industry Players: Distribution by Number of Patents
Figure 9.10 Leading Individual Assignees: Distribution by Number of Patents
Figure 9.11 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
Figure 9.12 Patent Analysis: Year-wise Distribution of Patents by Age, 2001-2021
Figure 9.13 DNA Cloning: Patent Valuation Analysis
Figure 10.1 Global DNA Cloning Kits Market, 2022-2035 (USD Million)
Figure 10.2 DNA Cloning Kits: Likely Growth Scenarios
Figure 10.3 DNA Cloning Kits Market: Distribution by Type of Cloning Method, 2022 and 2035
Figure 10.4. DNA Cloning Kits Market for Blunt End Cloning, 2022-2035 (USD Million)
Figure 10.5 DNA Cloning Kits Market for Ligase Independent Cloning, 2022-2035 (USD Million)
Figure 10.6 DNA Cloning Kits Market for PCR Cloning, 2022-2035 (USD Million)
Figure 10.7 DNA Cloning Kits Market for Seamless Cloning, 2022-2035 (USD Million)
Figure 10.8 DNA Cloning Kits Market for TA Cloning, 2022-2035 (USD Million)
Figure 10.9 DNA Cloning Kits Market for Other Methods, 2022-2035
Figure 10.10 DNA Cloning Kits Market: Distribution by End User, 2022- 2035 (USD Million)
Figure 10.11 DNA Cloning Kits Market for Academic and Research Institutes, 2022-2035 (USD Million)
Figure 10.12 DNA Cloning Kits Market for Pharmaceutical and Biotechnology Companies, 2021-2035 (USD Million)
Figure 10.13 DNA Cloning Kits Market for Hospitals and Clinics, 2022-2035 (USD Million)
Figure 10.14 DNA Cloning Kits Market for Other End-users, 2022-2035 (USD Million)
Figure 10.15 DNA Cloning Kits: Distribution by Geography, 2022 and 2035
Figure 10.16 DNA Cloning Kits Market in North America, 2022-2035 (USD Million)
Figure 10.17 DNA Cloning Kits Market in Europe, 2022-2035 (USD Million)
Figure 10.18 DNA Cloning Kits Market in Asia Pacific, 2022-2035 (USD Million)
Figure 10.19 DNA Cloning Kits Market in Latin America, 2022-2035 (USD Million)
Figure 10.20 DNA Cloning Kits Market in Middle East and North Africa, 2022-2035 (USD Million)
Figure 11.1. DNA Cloning Service Providers: Distribution by Year of Establishment
Figure 11.2. DNA Cloning Service Providers: Distribution by Company Size
Figure 11.3. DNA Cloning Service Providers: Distribution by Region of Headquarters
Figure 11.4. DNA Cloning Service Providers: Distribution by Location of Headquarters
Figure 11.5. DNA Cloning Service Providers: Distribution by Company Size and Region of Headquarters
Figure 12.1 Future Applications of Xenobots
Figure 13.1 Concluding Remarks: DNA Cloning Kits Market Landscape
Figure 13.2 Concluding Remarks: DNA Cloning Reagents Market Landscape
Figure 13.3 Concluding Remarks: Grant Analysis
Figure 13.4 Concluding Remarks: Publications Analysis
Figure 13.5 Concluding Remarks: Patent Analysis
Figure 13.6 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 4.1 DNA Cloning Kits: Information on Number of Reactions and Kit Components
Table 4.2 DNA Cloning Kits: Information on Cloning Method and Type of Fragment(s) Cloned
Table 4.3 DNA Cloning Kits: Information on Efficacy, Cloning Time, Shelf Life and Kit Price
Table 4.4 DNA Cloning Kit Providers: List of Players
Table 5.1 DNA Cloning Reagents: Information on Unit Size, Reagent Components and Concentration
Table 5.2 DNA Cloning Reagents: Information on Product Overhangs, Exonuclease Activity, Storage Temperature and Price
Table 5.3 DNA Cloning Reagent Providers: List of Players
Table 6.1 DNA Cloning Kit and Reagent Providers: List of Companies Profiled
Table 6.2 Thermo Fisher Scientific: Company Snapshot
Table 6.3 DNA Cloning Kit Portfolio
Table 6.4 DNA Cloning Reagent Portfolio
Table 6.5 Recent Developments and Future Outlook
Table 6.6 Merck: Company Snapshot
Table 6.7 DNA Cloning Kit Portfolio
Table 6.8 DNA Cloning Reagent Portfolio
Table 6.9 Recent Developments and Future Outlook
Table 6.10 Takara Bio: Company Snapshot
Table 6.11 DNA Cloning Kit Portfolio
Table 6.12 DNA Cloning Reagent Portfolio
Table 6.13 Recent Developments and Future Outlook
Table 6.14 Vazyme: Company Snapshot
Table 6.15 DNA Cloning Kit Portfolio
Table 6.16 GenScript: Company Snapshot
Table 6.17 DNA Cloning Kit Portfolio
Table 6.18 Recent Developments and Future Outlook
Table 6.19 Promega: Company Snapshot
Table 6.20 DNA Cloning Reagent Portfolio
Table 6.21 Agilent Technologies: Company Snapshot
Table 6.22 DNA Cloning Reagent Portfolio
Table 6.23 Recent Developments and Future Outlook
Table 6.24 Bio-Rad: Company Snapshot
Table 6.25 DNA Cloning Reagent Portfolio
Table 6.26 Recent Developments and Future Outlook
Table 9.1 Patent Analysis: Prominent CPC Symbols
Table 9.2 Patent Analysis: List of Top CPC Symbols
Table 9.3 Patent Analysis: Most Popular CPC Symbols
Table 9.4 Patent Analysis: Summary of Benchmarking Analysis
Table 9.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 9.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 9.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 11.1 DNA Cloning Service Providers: List of Players
Table 14.1 SBS Genentech: Company Snapshot
Table 14.2 Canvax Biotech: Company Snapshot
Table 15.1 DNA Cloning Kits: Distribution by Kit Components
Table 15.2 DNA Cloning Kits: Distribution by Number of Reactions
Table 15.3 DNA Cloning Kits: Distribution by Type of Cloning Method Used
Table 15.4 DNA Cloning Kits: Distribution by Cloning Time
Table 15.5 DNA Cloning Kits: Distribution by Type of Fragment(s) Cloned
Table 15.6 DNA Cloning Kits: Distribution by Efficacy
Table 15.7 DNA Cloning Kits: Distribution by Kit Shelf Life
Table 15.8 DNA Cloning Kits: Distribution by Kit Price
Table 15.9 DNA Cloning Kit Providers: Distribution by Year of Establishment
Table 15.10 DNA Cloning Kit Providers: Distribution by Company Size
Table 15.11 DNA Cloning Kit Providers: Distribution by Region of Headquarters
Table 15.12 DNA Cloning Kit Providers: Distribution by Location of Headquarters
Table 15.13 DNA Cloning Kit Providers: Distribution by Company Size and Region of Headquarters
Table 15.14 Leading Players: Distribution by Number of DNA Cloning Kits
Table 15.15 DNA Cloning Reagents: Distribution by Unit Size
Table 15.16 DNA Cloning Reagents: Distribution by Concentration (units/μl)
Table 15.17 DNA Cloning Reagents: Distribution by Reagent Components
Table 15.18 DNA Cloning Reagents: Distribution by Exonuclease Activity
Table 15.19 DNA Cloning Reagents: Distribution by Product Overhangs
Table 15.20 DNA Cloning Reagents: Distribution by Heat Inactivation Temperature
Table 15.21 DNA Cloning Reagents: Distribution by Storage Temperature
Table 15.22 DNA Cloning Reagents: Distribution by Reagent Price
Table 15.23 DNA Cloning Reagent Providers: Distribution by Year of Establishment
Table 15.24 DNA Cloning Reagent Providers: Distribution by Company Size
Table 15.25 DNA Cloning Reagent Providers: Distribution by Region of Headquarters
Table 15.26 DNA Cloning Reagent Providers: Distribution by Location of Headquarters
Table 15.27 DNA Cloning Reagent Providers: Distribution by Company Size and Region of Headquarters
Table 15.28 Leading Players: Distribution by Number of Products
Table 15.29 Thermo Fisher Scientific: Annual Revenues, 2017-2021 (USD Billion)
Table 15.30 Merck: Annual Revenues, 2017- 2021 (EUR Billion)
Table 15.31 Takara Bio: Annual Revenues, 2017-9M 2022 (JPY Billion)
Table 15.32 GenScript: Annual Revenues, 2016- 2021 (USD Billion)
Table 15.33 Agilent Technologies: Annual Revenues, 2017- 1M 2022 (USD Billion)
Table 15.34 Bio-Rad: Annual Revenues, 2017- 2021 (USD Billion)
Table 15.35 Publication Analysis: Cumulative Year-wise Trend, 2018-2022 (till January)
Table 15.36 Publication Analysis: Distribution by Type of Article
Table 15.37 Publication Analysis: Distribution by Type of Publication
Table 15.38 Popular Publishers: Distribution by Number of Publications
Table 15.39 Popular Journals: Distribution by Number of Publications
Table 15.40 Popular Journals: Distribution by Journal Impact Factor
Table 15.41 Publication Analysis: Distribution by Geography
Table 15.42 Grant Analysis: Cumulative Year-Wise Trend, 2017-2022 (till January)
Table 15.43 Grant Analysis: Distribution by Amount Awarded (USD Million), 2017-2022 (till January)
Table 15.44 Grant Analysis: Distribution by Administering Institute Center
Table 15.45 Grant Analysis: Distribution by Support Period
Table 15.46 Grant Analysis: Distribution by Type of Grant Application
Table 15.47 Grant Analysis: Distribution by Purpose of Grant Award
Table 15.48 Grant Analysis: Distribution of Amount Awarded by Purpose of Grant
Table 15.49 Grant Analysis: Distribution by Activity Code
Table 15.50 Grant Analysis: Distribution by Study Section
Table 15.51 Popular Program Officers: Distribution by Number of Grants
Table 15.52 Popular Recipient Organizations: Distribution by Number of Grants
Table 15.53 Popular Recipient Organizations: Distribution by Amount Awarded (USD Million)
Table 15.54 Grant Analysis: Distribution by Location of Recipient Organizations
Table 15.55 Patent Analysis: Distribution by Type of Patent
Table 15.56 Patent Analysis: Cumulative Distribution by Publication Year, 2017-2021
Table 15.57 Patent Analysis: Cumulative Distribution by Application Year, 2017-2021
Table 15.58 Patent Analysis: Distribution by Geographical Location
Table 15.59 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2017-2021
Table 15.60 Leading Industry Players: Distribution by Number of Patents
Table 15.61 Leading Non-Industry Players: Distribution by Number of Patents
Table 15.62 Leading Individual Assignees: Distribution by Number of Patents
Table 15.63 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
Table 15.64 DNA Cloning: Patent Valuation Analysis
Table 15.65 Patent Analysis: Year-wise Distribution of Patents by Age, 2001-2021
Table 15.66 Global DNA Cloning Kits Market, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.67 DNA Cloning Kits Market, 2022 and 2035: Distribution by Type of Cloning Method Used
Table 15.68 DNA Cloning Kits Market for Blunt End Cloning, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.69 DNA Cloning Kits Market for Ligase Independent Cloning, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.70 DNA Cloning Kits Market for PCR Cloning, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.71 DNA Cloning Kits Market for Seamless Cloning, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.72 DNA Cloning Kits Market for TA Cloning, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.73 DNA Cloning Kits Market for Other Methods, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.74 DNA Cloning Kits Market for Academic and Research Institutes, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.75 DNA Cloning Kits Market for Pharmaceutical and Biotechnology Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.76 DNA Cloning Kits Market for Hospitals and Clinics, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.77 DNA Cloning Kits Market for Other End-users, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.78 DNA Cloning Kits Market, 2022 and 2035: Distribution by Geography (USD Million)
Table 15.79 DNA Cloning Kits Market in North America, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.80 DNA Cloning Kits Market in Europe, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.81 DNA Cloning Kits Market in Asia-Pacific, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.82 DNA Cloning Kits Market in Latin America, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.83 DNA Cloning Kits Market in Middle East and North Africa, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.84 DNA Cloning Service Providers: Distribution by Year of Establishment
Table 15.85 DNA Cloning Service Providers: Distribution by Company Size
Table 15.86 DNA Cloning Service Providers: Distribution by Region of Headquarters
Table 15.87 DNA Cloning Service Providers: Distribution by Location of Headquarters
Table 15.88 DNA Cloning Service Providers: Distribution by Company Size and Region of Headquarters

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. AbFrontier
  2. Applied Biological Materials
  3. ABP Biosciences
  4. Addgene
  5. Agilent Technologies
  6. America Diagnostics
  7. Amid Biosciences
  8. AMSBIO
  9. Applied Biosystems
  10. AstraZeneca
  11. BPS Bioscience
  12. Bio-Fab Research
  13. Bioline (acquired by Meridian Bioscience)
  14. Biomiga
  15. Bioneer 
  16. Bionics
  17. Bio-Rad Laboratories
  18. BioServ
  19. BIOSS Centre for Biological Signalling Studies
  20. Blue Heron Biotech (acquired by Eurofins Genomics)
  21. Broad Institute
  22. Boston University Medical Campus (BUMC)
  23. Cambridge Bioscience
  24. Canvax Biotech
  25. Cellecta
  26. Cellomics Technology 
  27. Charles River Laboratories
  28. Chromous Biotech
  29. Codex DNA
  30. Columbia University
  31. Columbia University Irving Medical Center (CUIMC)
  32. Commonwealth Scientific and Industrial Research Organisation (CSIRO)
  33. Creative Biogene
  34. Creative Biolabs
  35. Credora
  36. Curia (formerly AMRI)
  37. Cytiva
  38. Dana-Farber Cancer Institute 
  39. Dow AgroSciences
  40.  Duke University
  41. DuPont 
  42. Elpis Biotech
  43. Enzynomics 
  44. Epoch Life Science
  45. Eurofins
  46. Exonbio
  47. Fisher Scientific
  48. Fraser International College (FIC)
  49. Fred Hutchinson Cancer Research Center
  50. Friedrich Miescher Institute for Biomedical Research
  51. GCC Biotech
  52. Gemini Biosciences
  53. GENAXXON bioscience
  54. GeneCust
  55. Genei 
  56. geneOmbio Technologies
  57. General Biosystems
  58. Genentech
  59. GENEWIZ
  60. GenScript
  61. Harvard University
  62. Hologic
  63. IBA Lifesciences
  64. Innoprot
  65. Intact Genomics
  66. Invitrogen
  67. J. Craig Venter Institute (JCVI)
  68. Jackson Laboratory
  69. Johns Hopkins University
  70. Labtoo
  71. Lamda Biotech
  72. Leland Stanford Junior University
  73. Massachusetts Institute of Technology
  74. MedGenome
  75. Merck
  76. Meridian Bioscience
  77. Molecular Cloning Laboratories (MCLAB)
  78. Molecular Diagnostic Services
  79. National Cancer Institute (NCI)
  80. National Center for Advancing Translational Sciences (NCATS)
  81. National Center for Complementary and Integrative Health (NCCIH)
  82. National Human Genome Research Institute (NHGRI)
  83. National Institute for Health and Medical Research (INSERM)
  84. National Institute of Allergy and Infectious Diseases (NIAID)
  85. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  86. National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  87. National Institute of Child Health and Human Development (NICHD)
  88. National Institute of Dental and Craniofacial Research (NIDCR) 
  89. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  90. National Institute of Environmental Health Sciences (NIEHS)
  91. National Institute of General Medical Sciences (NIGMS)
  92. National Institute of Mental Health (NIMH) 
  93. National Institute of Neurological Disorders and Stroke (NINDS) 
  94. National Institute on Aging (NIA) 
  95. National Institute on Deafness and Other Communication Disorders (NIDCD)
  96. National Institute on Drug Abuse (NIDA)
  97. National Institute on Minority Health and Health Disparities (NIMHD)
  98. New England Biolabs
  99. Novozymes
  100. National Heart, Lung, and Blood Institute (NHLBI)
  101. Novozymes
  102. Nuclear Energy Institute (NEI)
  103. NZYTech 
  104. Office of the Director (OD)
  105. OriCiro Genomics
  106. OriGene Technologies
  107. Patheon
  108. Pioneer
  109. Precision BioSciences
  110. Promega
  111. Protein Ark
  112. QIAGEN 
  113. Quintara Biosciences
  114. Roche
  115. SBS Genetech
  116. SciGenom Labs
  117. Sentebiolab
  118. Signosis
  119. Stanford University
  120. Synbio Technologies
  121. Synovance
  122. Takara Bio
  123. Texas A&M Health Science Center
  124. Thermo Fisher Scientific
  125. Trenzyme
  126. Twist Bioscience 
  127. Unity Lab Services
  128. University of Alabama
  129. University of California
  130. University of Helsinki
  131. University of Minnesota
  132. University of North Carolina 
  133. University of Pennsylvania 
  134. University of Queensland
  135. University of Vienna
  136. University of Washington
  137. Vazyme
  138. VectorBuilder
  139. Veterans Affairs (VA) 
  140. WZ Biosciences
  141. Yale University
  142. Zymerge

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 8) n a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com